Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

CorrigendumHepatology Free access | 10.1172/JCI17740C1

Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis

Ali Canbay, Maria Eugenia Guicciardi, Hajime Higuchi, Ariel Feldstein, Steven F. Bronk, Robert Rydzewski, Makiko Tanai, and Gregory J. Gores

Find articles by Canbay, A. in: JCI | PubMed | Google Scholar

Find articles by Guicciardi, M. in: JCI | PubMed | Google Scholar

Find articles by Higuchi, H. in: JCI | PubMed | Google Scholar

Find articles by Feldstein, A. in: JCI | PubMed | Google Scholar

Find articles by Bronk, S. in: JCI | PubMed | Google Scholar

Find articles by Rydzewski, R. in: JCI | PubMed | Google Scholar

Find articles by Tanai, M. in: JCI | PubMed | Google Scholar

Find articles by Gores, G. in: JCI | PubMed | Google Scholar

Published July 1, 2004 - More info

Published in Volume 114, Issue 1 on July 1, 2004
J Clin Invest. 2004;114(1):142–142. https://doi.org/10.1172/JCI17740C1.
© 2004 The American Society for Clinical Investigation
Published July 1, 2004 - Version history
View PDF

Original citation: J. Clin. Invest.112:152–159(2004). doi:10.1172/JCI17740.

Citation for this Corrigendum: J. Clin. Invest.114:142 (2004). doi:10.1172/JCI17740C1.

The authors wish to correct errors and provide further clarification regarding this manuscript. Figure 2a was reproduced from a previous publication (Canbay et al. Gastroenterology. 123:1323–1330 [2002]). An appropriate photomicrograph from concurrent control mice is depicted below and should replace the original.

In addition, although wild-type and cathepsin B–/– mice originated from the same litter, they were subsequently bred as homozygotes for this study and therefore were not concurrent littermates as was indicated in the study.

Version history
  • Version 1 (July 1, 2004): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts